Us Fda Issue

ALL
News
Opinion
Photos
Videos

Jump to

USFDA issues 3 observations to Aurobindo Pharma's Unit-XI

Aurobindo’s Unit XI was inspected by US FDA between July 25-Aug 2, 2022 and issued three observations.
New launches to drive earnings growth in FY18 & FY19: Glenmark

The company has a strong pipeline of products which the company, CMD Glenn Saldanha said adding that new launches will drive earnings for the company in FY18 and FY19. The company has no plans to raise further capital, he said.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Us Fda Issue

USFDA issues 3 observations to Aurobindo Pharma's Unit-XI

New launches to drive earnings growth in FY18 & FY19: Glenmark